chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got the vaccination and still got shingles, suspected vaccination failure; I got the vaccination and still got shingles; six bumps; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and papular rash. On an unknown date, the outcome of the vaccination failure, shingles and papular rash were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and papular rash to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient for himself/herself. The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication. The patient received the shingles shot and still got shingles, but only had six bumps and that was enough.  The vaccination had helped the patient. This case was considered as suspected vaccination failure, since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were not provided.
This patient was under the approved age (16 years old) for a Moderna vaccine. The patient had previously received two doses of Pfizer vaccine and the patient and his mother both signed up online to get the Moderna booster instead of Pfizer. The Moderna vaccine was administered to both individuals. The patient has not reported any adverse effects or outcomes thus far.
Within about 20 minutes of vaccination, pt developed chest/abdominal pain, dizziness, malaise, headache, DIB. Pulse OX 98 and exam was normal. Resolved on its own in about an hour.
Rcd shot 9/18 started 9/19 pain, swelling redness, rash. Worse daily. Went to clinic 9/22. Warm to touch, 3x5 rash, hard.
pt recv vax & 23JUN96 pt delivered by Caesarean section a nl male two months premature;baby devel elevated bilirubin & was monitored in high-risk hosp unit;
localized redness and swelling 0600 which spread noted at 1830, itching 1830
Onset 48 hrs S/P flu shot (9/13 through 9/15) - history of transverse myelitis, restless legs and (R) obturator schwannoma progressing to severe unremitting leg pain (9/15 PM - increased RLS - 9/16 AM), myalgia's legs greater than arms, low-grade temp (to 100.8), diaphoretic, chills, anorexia, mild cough/phlegm, profoundly fatigued (slept all weekend). Legs "rubbery".
Severe  Knee pain on both knees but worse on the right knee (pain is experienced when I walk, climb stairs, lie down, sit down) Extreme fatigue, weakness, tiredness, and sleepiness Severe right wrist pain (making it difficult to open a bottle cap or jar) Headaches Neck pain and pain on the back of my head Blurry vission
Patient expired 11/9/03  Cause of death  following autopsy:  Fatal Heart Disease (Athero- sclerotic heart disease) Fatal Arrythmia Diabetic Related
Patient has developed Alopecia areata (AA) is a common autoimmune disease characterized by non-scarring hair loss. New onsets of AA have been associated with coronavirus disease 2019 (COVID-19).
pt recv vax & devel sore throat, cough, fever  h/a in less than 24hr;
Both his ankles were swollen up a little; Discomfort on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Both his ankles were swollen up a little) and VACCINATION SITE DISCOMFORT (Discomfort on the injection site) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included HYDROXYCHLOROQUINE, FINASTERIDE and TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF) for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE DISCOMFORT (Discomfort on the injection site). On 07-Feb-2021, the patient experienced JOINT SWELLING (Both his ankles were swollen up a little). On 06-Feb-2021, VACCINATION SITE DISCOMFORT (Discomfort on the injection site) had resolved. On 09-Feb-2021, JOINT SWELLING (Both his ankles were swollen up a little) had resolved.            Reporter did not allow further contact
Sterile Abscess noted left thigh, red, swollen on 3/9/06 DR, 3/10/06 started Augmentin 500 5cc  PO BID x 10 days, 3/11/06 seen again recheck, large local allergic reaction.
Father, not patient, contracted chicken pox. Healthy, white male, 39 years old, no complications resulted.
This spontaneous report was received from a pharmacist refers to a approximately 62 year old female patient with sulfa allergy. The patient's medical history included lymph node removal about 20 years ago approximately in 1993. On an unknown date, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent)(Manufacturer unknown)(lot#, route, dose not reported). No concomitant medications were reported. On an unknown date, the patient experienced severe injection site swelling after she received the vaccine. The outcome of injection site swelling was reported as recovered. The relatedness of the event with pneumococcal vaccine, polyvalent (23-valent)(Manufacturer unknown) was unknown. Additional information has been requested.
Oval hyperemic swelling on Rt upper arm at injection site 1"/1'/2"
Pretty much I have a swollen Lymph gland in my neck and this happened after my fifth COVID-19 vaccination.
Vaccine that administered beyond use date after the thaw process/expired vaccine administered; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 03-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter  Patient age was reported as 58 years and 10 months.  Ndc Code was mentioned. It was reported that on 10-Jun-2022 Medical was notified of an audit that was done and were then made aware of vaccines that were administrated beyond use date after the thaw process. There was no patient that had any adverse reactions and no reports of any reactions after the administration of the vaccines.  No treatment medication was provided by the reporter.
Injection site became tender, hot and itchy.  Applied over the counter anti itch medication.
Initial and follow-up information has been received from a physician concerning a 63 year old female with high blood pressure and high cholesterol and no allergies, who on 15-JUN-2007 was vaccinated with ZOSTAVAX (Merck). Lot # 657676/0619U, intramuscularly into her left deltoid. Concomitant therapy possibly included Simvastatin (MSD) and Lisinopril (manufacturer unknown). It was reported that the patient on 30-JAN-2008 developed shingles. It began as pain only, in back and to right side at about T6-T8 level dermatome. Pain increased and red, vesicular rash appeared in dermatomal band on 06-FEB-2008 (previously reported as shortly before 07-FEB-2008). Patient was given ZOVIRAX, prednisone, and LYRICA. But she still developed postherpetic neuralgia. The symptoms persisted for approximately two months. On approximately 18-MAR-2008 (previously reported as by April 2008), the patient has completely recovered. There were no laboratory test performed, in follow-up information the physician also reported "unfortunately, no testing of vesicles was done (because the rash and pain were pathognomonic for herpes zoster)". In follow-up information shingles and post-herpetic neuralgia were considered to be and other important medical events. No further information is available.
4 hours chattering, freezing cold, felt like a block of ice, had layers of clothes. If touched myself did not have cold hands but was freezing inside out. Extreme headache, could not watch TV. Lasted 5 days went away, notified doctor. 7-10 days later, symptoms came back. Last 2 days and go away and come back.
Nausea, mild on the day of the vaccine. Five days after the vaccination I felt nausea again, a strange taste in my mouth, and a headache. resembling the senses with the injection of prolia.
2x2 inch dark bruising fever in shot arm; Swelling in shot arm around bruising; Redness in shot arm around bruising; Redness in shot arm around bruising and hurts; fever in shot arm; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via an unspecified route of administration in the left arm on 18Mar2021 at 13:15 (at the age of 74-years-old), as a single dose for COVID-19 immunisation. Medical history included breast cancer in 1991, hysterectomy in 1995 and abdominal surgery in 2017. The patient did not have any allergies to medications, food, or other products. Concomitant medications included bupropion (WELLBUTRIN XL) tablet 150mg once a day from an unknown date for unknown indication and levothyroxine sodium (SYNTHROID) tablet 50 (unspecified units) from an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201), via an unspecified route of administration in the left arm on 25Feb2021 at 12:30 (at the age of 74-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 18Mar2021 at 16:45, the patient had 2x2 inch dark bruising fever in shot arm (vaccinated arm), swelling and redness around bruising and it hurts. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of vaccination site bruising, fever, swelling, redness in shot arm around bruising and hurts were not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Immediately had shar burning pain at site. Pain continued severely for many months Pain has lessened , but persist: it is now 2/21/2022. I needed an arm sling, various topical pain treatments; no relief. Reported to my primary care doctor. I kept months of records. First several months it felt like I was getting many (50+/day) injections daily. Burning pain that would sometimes emanate down whole arm. My opinion: improper administration of vaccine. I have never had this kind of pain with injection. General fatigue, nausea persisted for 3+ weeks after injection.
This spontaneous report was received from a medical assistant and refers to unspecified patients of unknown age and gender. No information about the patients' medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB injection, lot # M037248, expiration date: 21-FEB-2019 (dose and route of administration were not reported). The vaccine was exposed to temperature below 32 degrees Fahrenheit (0 degrees Celsius), the lowest temperature was minus 40 degrees Fahrenheit for 1 cycle. The vaccine was exposed to incorrect temperature for 6 days 23 hours and 30 minutes. Digital data logger was involved and there was no previous temperature excursion. No adverse effects were reported. Product quality compliant was not involved. This one of several reports received from the same reporter.   Additional information has been requested. Sender's Comments: US-009507513-1702USA002783: US-009507513-1702USA002784: US-009507513-1701USA011637.
he was taking 80 mg of Aspirin continuously for his heart since he was not advised not to take it; sore arm; This is a spontaneous report from a contactable consumer (patient).   A 72-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1, via an unspecified route of administration on 28Jan2021 (age at vaccination 72 years) at 1 st dose single for covid-19 immunisation and dose 2, via an unspecified route of administration on 22Feb2021 (age at vaccination 72 years) at 2 nd dose single for covid-19 immunisation. The patient medical history included blood thinning (he says during that time he was taking 81 mg aspirin nightly for his heart, for blood thinning, which he has done for years.) and his heart. Concomitant medication included acetylsalicylic acid (BABY ASPIRIN) from an unspecified date at 81 mg daily for blood thinning and for his heart. The patient stated that, during the time the first and second doses of the vaccine were administered to him on 28Jan2021 and 22Feb2021, respectively, he was taking 81 mg of Aspirin continuously nightly for his heart and for blood thinning which he has done for years and he was wondering if it has affected the efficacy of the vaccine. He denied to having any bruising or bleeding problems and just experienced a sore arm. The patient was not told to take Aspirin while taking the vaccine, then he was told by someone he talked to as it can reduce efficacy for vaccine. The patient said he has had no reactions to drugs. Since he was not advised to take it but now, he stopped after hearing he should not take the medication when getting the vaccine as it can reduce efficacy for vaccine. The patient discontinued his medication for 3 days. The patient wanted to know if taking the Aspirin 80 mg for his heart during the two doses of the Covid-19 vaccine may affect the efficacy of the vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained
Client called 2 days after receiving 2nd dose of HPV 9 and reported having muscle aches in legs, arms, shoulders and wrists bilaterally. She also c/o head cold symptoms at the same time. Stated she wasn't sure if that had started before receiving vaccines. Instructed client to call back if s/s do not subside. Also instructed client that a VAERS report would be made and that this RN reporting would ask the experts if she should receive the 3rd dose.
I was vaccinated twice and still got the shingles/suspected vaccination failure; Still got the shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 6-June-2022 Reporter's comment: This case was reported by a consumer via interactive digital media. The patient was vaccinated twice and still got the shingles. The patient stated that he/she head that the shot only last 3 to 4 years. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles was not provided.
I refer there is Myocarditis thing; When he took a deep breath in, he had, it is like chest pain like it is crampy; This is a spontaneous report from a contactable consumer (parent). This consumer reported for his son. A 13-year-old male patient second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number- EW0168 and expiration date was 30Nov2021), via an unspecified route of administration on 25Aug2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medication were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number- EW0168), via an unspecified route of administration on unspecified date as DOSE 1, SINGLE for COVID-19 immunisation. The reporter stated that when his son took a deep breath in, he had, it was like chest pain like it was crampy. Reporter referred there was Myocarditis thing and patient had same thing in next morning like when he took a deep breath in there was some like chest pain in there. The outcome of events was unknown.  Follow-up attempts were completed. No further information was expected.
Before I begin let me frame things.  I am listing my receiving of the Pfizer shot, but on April 8, 2021 I received the one shot Johnson & Johnson vaccine.  In July as the delta variant was becoming more prominent I was strongly encouraged by my girlfriend and my mother to get a mRNA vaccine as well.   I got the Pfizer shots at the walk up clinics, where they did not ask if I had had any other vaccines.    Two days after the final vaccination shot (7/16) I remember feeling very fatigued.  So much so that I had to leave lunch and lie down.  I continued to feel run down and a lack of energy for the week, but nothing to make me concerned.  That Friday night (7/23) I started feeling feverish to the point where it was disturbing my sleep.   Sunday night (7/25) I awoke with a 102° fever and become worried that I was infected with COVID.  The next day (7/26) I took a COVID test, but it came back negative two days later.  I continued to have fevers that lasted 10-12 hours around 101-102° every day.  On Thursday (7/29) I asked for help from my doctor to relieve these symptoms.  They ordered a blood test and chest x-ray.  On Sunday (8/1) I had a doctors appt and she recommended I by admitted to the emergency room where I got fluids.   I was released later that day with still no diagnosis.  On 8/2 I finally got a call informing me that I was infected with mononucleosis.
Sore arm; Rash on the Forearms, Groin area (Both inner sides), and Upper left arm. Feels that the Rash is spreading; feels very Tired; Rash area is Bumpy and itching; Rash area is Bumpy and itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Rash area is Bumpy and itching), NODULE (Rash area is Bumpy and itching), PAIN IN EXTREMITY (Sore arm), RASH (Rash on the Forearms, Groin area (Both inner sides), and Upper left arm. Feels that the Rash is spreading) and FATIGUE (feels very Tired) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced PRURITUS (Rash area is Bumpy and itching), NODULE (Rash area is Bumpy and itching), RASH (Rash on the Forearms, Groin area (Both inner sides), and Upper left arm. Feels that the Rash is spreading) and FATIGUE (feels very Tired). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PRURITUS (Rash area is Bumpy and itching), NODULE (Rash area is Bumpy and itching), PAIN IN EXTREMITY (Sore arm), RASH (Rash on the Forearms, Groin area (Both inner sides), and Upper left arm. Feels that the Rash is spreading) and FATIGUE (feels very Tired) had resolved.            No relevant concomitant medications were reported. Patient reported that she had some sort of bug infestation in her home which affected her and the rash had coincided  with the night she received the shot. Treatment information was not provided.  The action taken for mRNA-1273 was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow up information was received and new event,  the outcome of the events were updated.
Sore injection site; Body aches; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 22Sep2023 at 13:00 as dose 4 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; influenza vaccine (FLU [INFLUENZA VACCINE]), on 22Sep2023 as dose number unknown, single (Batch/Lot number: unknown) for influenza immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: STOOL SOFTENER. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 immunisation. The following information was reported: PAIN (non-serious) with onset 22Sep2023 at 22:00, outcome "not recovered", described as "Body aches"; HEADACHE (non-serious) with onset 22Sep2023 at 22:00, outcome "not recovered"; VACCINATION SITE PAIN (non-serious) with onset 22Sep2023 at 22:00, outcome "not recovered", described as "Sore injection site". Therapeutic measures were not taken as a result of vaccination site pain, pain, headache.  Additional information: Patient had not have covid prior to vaccination and not tested covid post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient reported painful testicles, tried ibuprofen with no resolution. Pharmacist recommended  he go to urgent care for medical attention and he left the pharmacy.  Pt has no pcp.
AFTER THREE DAY OF VACCINE THE PATIENT EXPERIMENTED: SLEEP APNEA,  HOARSELY AND URGENCY ( URINE INFECTION)
we do heart palpitations in; This is a spontaneous report from a contactable consumer (patient's husband). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0173), via an unspecified route of administration on an unspecified date as 1ST DOSE, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. He and her wife both had the shots about a month ago, it's kind of interesting that we do heart palpitations in. The outcome of the event was unknown.  Follow-up attempts are needed. Information on Lot/Batch number was available, additional information has been requested